Adverse event detection in social media requires sophisticated technology that can identify potential safety signals in multiple languages and contexts. Manual monitoring is time-consuming and error-prone, while generic tools miss critical mentions. Companies need real-time alerting that can distinguish between casual complaints and genuine safety concerns, while ensuring all regulatory reporting requirements are met.

European pharmaceutical companies face increasingly strict regulatory requirements around social media monitoring. From GDPR compliance to EMA guidelines on adverse event reporting, maintaining compliance while gathering meaningful insights is complex. Companies need a solution that automatically identifies and flags regulatory concerns while providing actionable intelligence across multiple jurisdictions.